Safety and Effectiveness of Edoxaban in Japanese Venous Thromboembolism Patients - Final Analysis of One-Year Follow-up Data From a Japanese Postmarketing Observational Study (ETNA-VTE-Japan) [0.03%]
一项在日本开展的上市后观察性研究（ETNA-VTE-Japan）一年随访数据分析：利伐沙班在日本静脉血栓栓塞症患者中的安全性和有效性(final分析)
Mashio Nakamura,Norikazu Yamada,Tomohiko Asamura et al.
Mashio Nakamura et al.
Background: ETNA-VTE-Japan is a prospective, observational study conducted as part of a postmarketing study regarding the safety and effectiveness of edoxaban in Japanese patients with venous thromboembolism (VTE). The results of the final ...
Impact of Major Vascular Complication Access Site Status on Mortality After Transfemoral Transcatheter Aortic Valve Replacement - Results From the FinnValve Registry [0.03%]
股动脉入路经导管主动脉瓣植入术后主要血管并发症与患者预后的相关性-来自FinnValve注册研究的结果分析
Teemu Laakso,Noriaki Moriyama,Peter Raivio et al.
Teemu Laakso et al.
Background: The aim of this study was to investigate the impact of anatomical site status and major vascular complication (MVC) severity on the outcome of transfemoral transcatheter aortic valve replacement (TF-TAVR). Methods and Results: T...
Evaluation of Right Ventricular Function on Cardiac Magnetic Resonance Imaging and Correlation With Hemodynamics in Patients With Chronic Thromboembolic Pulmonary Hypertension [0.03%]
慢性肺栓塞性肺动脉高压患者心脏磁共振成像评估右心室功能及与血流动力学的相关性
Yoshio Nishina,Takumi Inami,Masaharu Kataoka et al.
Yoshio Nishina et al.
Background: Balloon pulmonary angioplasty (BPA) is an alternative therapy for chronic thromboembolic pulmonary hypertension (CTEPH). Right heart catheterization (RHC) is essential to evaluate the efficacy of BPA. Cardiac magnetic resonance ...
Zinc Deficiency and Clinical Outcome After Infrainguinal Bypass Grafting for Critical Limb Ischemia [0.03%]
低锌状态与股下旁路移植术治疗重症肢体缺血的临床结局的关系
Akio Koyama,Akio Kodama,Takuya Tsuruoka et al.
Akio Koyama et al.
Background: The aim of this study was to identify a relationship between zinc (Zn) deficiency and clinical outcome in patients with critical limb ischemia (CLI). Methods and Results: Forty-five limbs from 44 patients with CLI who underwent ...
Cardioprotective Effects of Rivaroxaban on Cardiac Remodeling After Experimental Myocardial Infarction in Mice [0.03%]
利伐沙班对小鼠实验性心肌梗死后心脏重塑的保护作用
Nobuhiro Nakanishi,Koichi Kaikita,Masanobu Ishii et al.
Nobuhiro Nakanishi et al.
Background: Direct-activated factor X (FXa) plays an important role in thrombosis and is also involved in inflammation via the protease-activated receptor (PAR)-1 and PAR-2 pathway. We hypothesized that rivaroxaban protects against cardiac ...
Impact of Age on Gender Differences in the Acute Myocardial Infarction Onset-Weather Association - Oita AMI Registry [0.03%]
年龄对急性心肌梗死发病-气象因素性别差异影响的队列研究——大分AMI注册库数据
Hidefumi Akioka,Kunio Yufu,Masahide Hara et al.
Hidefumi Akioka et al.
Background: The onset of acute myocardial infarction (AMI) is related to weather conditions, but the impact of age on gender differences in the AMI onset-weather association has not been elucidated. Methods and Results: We analyzed the Oita...
Differential Response to Heart Rate Reduction by Carvedilol in Heart Failure and Reduced Ejection Fraction Between Sinus Rhythm and Atrial Fibrillation - Insight From J-CHF Study [0.03%]
J-CHF研究的心室射血分数降低的心力衰竭患者在窦性心律和房颤时美托洛尔减慢心率效果的差异分析
Yuji Nagatomo,Tsutomu Yoshikawa,Hiroshi Okamoto et al.
Yuji Nagatomo et al.
Background: Heart rate (HR) reduction by β-blocker might not benefit patients with heart failure and reduced ejection fraction (HFrEF) with atrial fibrillation (AF). Methods and Results: The J-CHF study was a prospective randomized multice...
Wearable Cardioverter Defibrillator - Initial Experience in the Outpatient Setting in Japan [0.03%]
穿戴式心脏除颤器在日本门诊的初步应用体验
Ai Horiguchi,Jun Kishihara,Shinichi Niwano et al.
Ai Horiguchi et al.
Background: The wearable cardioverter defibrillator (WCD) has been available since 2014 in Japan, and its benefit in the in-hospital acute phase at high risk of ventricular tachyarrhythmia (VTA) has been established, but its clinical use in...
Paclitaxel Particle Distribution 3 Months After Drug-Coated Balloon Treatment - Zemporshe® Angioscopy Assessment [0.03%]
药物涂层球囊治疗后3个月的紫杉醇颗粒分布——Angioscopy评估（Zemporshe®）
Madoka Ihara,Yuhei Nojima,Hidenori Adachi et al.
Madoka Ihara et al.
Effect of Aggressive Lipid-Lowering Therapy in Single-Vessel vs. Multivessel Coronary Artery Disease Patients With Acute Coronary Syndrome - Heart Institute of Japan-Proper Level of Lipid Lowering With Pitavastatin and Ezetimibe in Acute Coronary Syndrome (HIJ-PROPER) Substudy [0.03%]
高强度降脂治疗对急性冠脉综合征单支病变与多支病变患者的疗效：日本心脏研究所ACS降脂达标研究(HIJ-PROPER)亚组分析
Masataka Ogiso,Junichi Yamaguchi,Erisa Kawada-Watanabe et al.
Masataka Ogiso et al.
Background: The effects of aggressive lipid-lowering therapy according to the number of diseased coronary arteries in acute coronary syndrome (ACS) are still controversial. This study investigated the efficacy of this therapy in ACS patient...